FDA Inspection 1021941 — Palo Alto Medical Foundation Reproductive Endocrinology and Infertility
The FDA completed an inspection of Palo Alto Medical Foundation Reproductive Endocrinology and Infertility on August 17, 2017 in San Jose, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 17, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Jose, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12277 | 21 CFR 1271.75(a)(1) | Risk factors, clinical evidence |